Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computer Vision for Predicting the Efficacy of Neoadjuvant Therapy in Breast Cancer.

Cancers·2026
Same author

SPHERpower: MSC spheroid-based bioequivalent lead to the efficient restoration of the scarred vocal folds.

Stem cell research & therapy·2026
Same author

Sex-Stratified Machine Learning for the Prediction of Post-COVID Condition: A Longitudinal Cohort Study.

Journal of clinical medicine·2026
Same author

Correction: Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2'-deoxy-2'-b-fluoro-4'-azidocytidine)-induced inhibition of Dalton's lymphoma growth and proliferation.

Discover oncology·2026
Same author

Comparison of Fascicular Turnover Flap and Autograft in a Rat Facial Nerve Model.

Journal of clinical medicine·2026
Same author

Liver-on-a-Chip: Searching for a Balance Between Biomimetics and Functionality.

Biosensors·2026

Related Experiment Video

Updated: Jun 28, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.3K

GBM Immunotherapy: Macrophage Impacts.

Nina Loginova1, Denis Aniskin1, Peter Timashev2

  • 1Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Centre "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Immunological Investigations
|April 18, 2024
PubMed
Summary

Tumor-associated macrophages (TAMs) promote glioblastoma (GBM) growth and treatment resistance. Targeting these cells offers a promising therapeutic strategy for this aggressive brain cancer.

Keywords:
Glioblastomaimmunotherapymacrophagetumor resistance

More Related Videos

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.5K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.0K

Related Experiment Videos

Last Updated: Jun 28, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.3K
In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.5K
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.0K

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Biology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
  • Standard treatments face challenges due to tumor heterogeneity, invasion, and the tumor microenvironment (TME).
  • The TME includes inflammatory cells like microglia and macrophages, crucial for tumor progression.

Purpose of the Study:

  • To review the role of tumor-associated macrophages (TAMs) in GBM development.
  • To explore TAMs as a therapeutic target for glioblastoma.
  • To summarize recent research on TAM properties and targeted therapeutic strategies.

Main Methods:

  • Literature review of studies over the past 5 years.
  • Analysis of TAMs' contribution to tumor proliferation, survival, and metastasis.
  • Examination of TAMs' role in immune suppression and treatment resistance.

Main Results:

  • TAMs release factors that enhance GBM proliferation, survival, and metastasis.
  • TAMs inhibit anti-tumor immune cell function, creating an immunosuppressive environment.
  • TAMs significantly contribute to GBM treatment resistance and aggressiveness.

Conclusions:

  • TAMs are key players in promoting glioblastoma development and therapeutic resistance.
  • Targeting TAMs represents a promising strategy for glioblastoma treatment.
  • Further research into TAM properties and molecular targets is essential for developing effective therapies.